HB 2081·MO·house
Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program
FailedFiled Dec 1, 2025
Sponsor: Ben Keathley
Latest Action
Referred: Emerging Issues(H)
May 15, 2026
Topics
Track this bill
Get real-time alerts when HB 2081 changes status, plus AI-powered summaries and stage predictions.
Sign up free